Increased metabolic demands in cancer could be responsible for obesity-related mitochondrial dysfunction since there were no changes in the protein level of PDH and citrate synthase in the CAAT of obese women with malignant tumors. This evidence concerns the gene CS and obesity due to melanocortin 4 receptor deficiency.